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Abstract 
 
The aim of this study was to examine the performance of the Health of the Nation Outcome 
Scales (HoNOS) against other measures of functioning and mental health in a full three-year 
cohort of admissions to a psychiatric hospital. A sample of N=1,719 patients (35.3% females, 
aged 17-78 years) was assessed using observer-rated measures and self-reports of 
psychopathology at admission. Self-reports were available from 51.7% of the sample (34.4% 
females, aged 17-76 years). Functioning and psychopathology were compared across five 
ICD-10 diagnostic groups: substance use disorders (SUD; F1), schizophrenia and psychotic 
disorders (F2), affective disorders (F3), anxiety/somatoform disorders (F4) and personality 
disorders (F6). Associations between the measures were examined, stratifying by diagnostic 
subgroup. The HoNOS were strongly linked to other measures primarily in psychotic 
disorders (except for the behavioral subscale), while those with SUD showed rather poor 
links. Those with anxiety/somatoform disorders showed null or only small associations. This 
study raises questions about the overall validity of the HoNOS.  It seems to entail different 
levels of validity when applied to different diagnostic groups. In clinical practice the HoNOS 
should not be used as a stand-alone instrument to assess outcome but rather as part of a more 
comprehensive battery including diagnosis-specific measures. 
Keywords: 
Health of the Nation Outcome Scales, validity, mental health, functioning, ICD-10  
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1. Introduction 
In mental health services there is increasing interest for evidence demonstrating the 
effectiveness of an intervention. In turn, several standardized tools have been developed for 
the assessment of treatment outcomes (Hampson et al., 2011; Slade, 2002; Slade et al., 1999). 
The Health of the Nation Outcome Scales (HoNOS) (Wing et al., 1998) were developed by 
the Research Unit of the Royal College of Psychiatrists in the 1990s, in order to provide a 
brief, accurate, and relevant measure of overall mental health and social functioning. Since 
then, the HoNOS has been successfully implemented as an outcome measure in the United 
Kingdom, Australia, and New Zealand and has been widely used in surveys in numerous 
European countries (Pirkis et al., 2005). A German version (HoNOS-D) was developed 
(Andreas et al., 2007) and subsequently validated (Andreas et al., 2010a; Andreas et al., 
2010b; Egger et al., 2015; Theodoridou et al., 2011). 
Previous research raised serious doubts on the original subscale structure (Preston, 2000; 
Trauer, 1999). Alternative solutions, however, were not only found to be clearly superior to 
the original subscales (Bech et al., 2003; Newnham et al., 2009; Speak et al., 2015), but also 
revealed that the 12 items of the HoNOS are not supposed to be independent (Speak and 
Muncer, 2015; Williams et al., 2014). Nevertheless the original structure is still in use in 
research and clinical practice (Speak et al., 2015).  
Although the psychometric properties of the HoNOS have been examined in large clinical 
samples (Speak and Muncer, 2015; Speak et al., 2015), only few studies have investigated 
their congruence to other psychometric scales across a broader spectrum of common mental 
disorders (Pirkis et al., 2005). Moreover, the HoNOS was originally developed and validated 
in clinical samples with large numbers of predominantly severe or chronic disorders (Wing et 
al., 1996); which challenges its utility for outcome monitoring of specific psychiatric 
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interventions, such as psychotherapy (Audin, 2001; Bebbington et al., 1999; Egger et al., 
2015). 
The aim of the current study was to examine the performance of the HoNOS to reflect clinical 
severity in a large sample of continuous admissions to a psychiatric hospital. Therefore, we 
examined a full 36-month sample of psychiatric inpatients across a broad diagnostic spectrum 
using a range of clinician- and patient-rated assessment scales. The performance of the 
HoNOS was examined by comparing the HoNOS scores against other well-validated 
measures for assessing psychopathology and functional impairment. By contrasting specific 
diagnostic groups we hoped to find evidence for the clinical specificity of the HoNOS. 
 
2. Method 
2.1. Sample and procedure 
The Department of Psychiatry, Psychotherapy and Psychosomatics as part of the Psychiatric 
University Hospital of Zurich specializes in treating “heavy users” (Roick et al., 2002a; Roick 
et al., 2002b), i.e. patients with frequent or long-term hospitalizations for whom outpatient 
treatment alone is often insufficient to prevent relapse (Stulz et al., 2012). 
We used data of a full three-year cohort of consecutive inpatients treated at our unit 
(N=1,913). Ten percent (10.14%; N=194) were initially dropped due to completely missing 
psychometric data. Dropouts did not differ from the remaining sample regarding sex, age, 
education, civil status and primary diagnosis at admission. The final study sample comprised 
N=1,719 patients (35.3% females) aged between 17 and 78 years (Mean=43.8; SD=11.8) 
from whom N=888 (51.7%) provided data on self-reported psychopathology. Self-reports of 
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the patients’ psychopathology were gathered within the first three days following admission 
to the hospital. The majority of the sample was single (52.4%) or divorced (27.1%), had 
completed an apprenticeship or technical college (54.3%), and had an average of 2.2 
(SD=4.1) hospital stays in our institution. More detailed information is provided in Table 1. 
2.2. Raters and Training 
Raters were clinicians, either psychiatrists, psychiatry residents or clinical psychologists. All 
raters were trained in specific workshops on the use and objectives of the measures used in 
the study. The workshops followed a standardized schedule, using case vignettes and videos 
of patients as examples. Refresher training sessions were provided on a regular basis, at least 
twice a year, with trainers being available for consultation at any time.  On all measures, 
information was rated retrospectively for the seven days prior to admission. All relevant 
information was derived from either the admission interview or directly by behavioral 
observation, while additional information was provided by the nursing staff, social workers 
and significant others. 
2.3. Diagnostic Groups 
On the basis of the primary diagnosis defined according to the International Classification of 
Diseases, 10th edition (ICD-10) (World Health Organization, 1992), the sample was divided 
into 5 diagnostic groups: substance use disorders (SUD) (ICD 10: F1), schizophrenia and 
other psychotic disorders (ICD 10: F2), affective disorders (ICD 10: F3), anxiety and 
somatoform disorders (ICD 10: F4), and personality disorders (PD) (ICD 10: F6). 
The data were collected as part of the routine clinical care procedure and therefore no specific 
written informed consent was obtained.  
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2.4. Measures 
2.4.1. HoNOS 
The HoNOS is an observer-rated scale and consists of 12 items with a five-point Likert scale 
response format from 0 (No problems) to 4 (Severe/very severe problems), scores above 2 are 
considered to be clinically significant. Although all scales were designed to be independent 
measures, they were combined into the following four dimensions of “behavior” 
(aggressiveness; non-accidental self-injury; problem drinking or drug-taking), “impairment” 
(cognitive problems; physical illness or disability problems), “symptoms” (hallucinations and 
delusions; depressed mood; other mental and behavioral problems) and “social problems” 
(problems with relationships; problems with activities related to daily living; problems with 
living conditions; problems with occupation and activities). Each subject could therefore be 
evaluated on subscale scores as well as on the total score.  The HoNOS showed good internal 
consistencies apart from the subscale of behavioral problems (see Cronbach Alpha 
coefficients in Table 2). 
2.4.2. Brief Symptom Inventory (BSI) 
The BSI (Derogatis and Melisaratos, 1983) is a 53-item self-report questionnaire assessing 
symptoms of psychological distress. As it is a short version of the 90-item Symptom-
Checklist (SCL-90; (Derogatis et al., 1976)), it can be used as a brief initial screening 
instrument as well as for outcome evaluation.  Each item is rated on a five-point Likert-scale 
from 0 (not at all) to 4 (extremely). General psychopathology is then assessed by means of a 
global score (GSI-Global severity index) when at least 40 out of the 53 items are checked. 
The total score ranges from 0 to 212.  
2.4.3. Global Assessment of Functioning (GAF) 
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The GAF is a 100-point single-item observer-rated scale. It rates overall functioning on a 
continuum from mental health to mental illness (Jean Endicott et al., 1976). The scale ranges 
from 1 (representing the most impaired individual) to 100 (representing the healthiest 
individual), 0 denoting insufficient information to make a clinical judgment. The GAF should 
be used to reflect overall functioning rated over the past seven days.  The GAF has been 
widely used to describe subject samples, to monitor change over time, to assess treatment 
effects, to describe the natural history of various conditions and to validate other measures. It 
is frequently used in psychiatric services as a general outcome measure. The main strengths of 
this scale are its ease of use with minimal training requirements, its reliability and sensitivity 
to change over time.  
2.4.4. Clinical Global Impression (CGI) 
The CGI scale is a widely used observer-rated tool for measuring clinical severity in 
psychiatry, and was originally introduced in psychopharmacological trials (Guy, 1976). The 
CGI was intended to provide a brief, universal stand-alone assessment of illness severity and 
ranges from 1 representing the “healthy subject” to 7 the “extremely ill subject”. Ratings of 
the CGI refer to the past week. The CGI correlates well with other standard measures across 
several psychiatric diagnoses (Leucht and Engel, 2006; Leucht et al., 2005; Spielmans and 
McFall, 2006). 
2.4.5. Mini-ICF 
The International Classification of Functioning (ICF) (World Health Organization, 2001) was 
introduced by the WHO in order to supplement the primarily symptom-related International 
Classification of Diseases (ICD-10) (World Health Organization, 1992). The ICF describes 
and classifies disorders according to the level of functioning and capacity – two entities, 
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which are linked to restrictions in social participation. However, the application of the ICF to 
clinical practice is rather restricted since its structure is highly complex and its daily 
application uneconomical. An abbreviated version, namely the Mini-ICF (Linden and Baron, 
2005), was developed, which can be used as a short observer-rated scale for assessing 
function. The Mini-ICF contains, analog to the original version of the ICF, thirteen domains 
of functioning: (1) adherence to regulations and routines, (2) planning and structuring of 
tasks, (3) flexibility, (4) competency/efficacy, (5) endurance, (6) assertiveness, (7) contact 
with others, (8) public exposure, (9) intimacy, (10) non-work activities, (11) self-
maintenance, (12) mobility and (13) competence to judge and decide. Each item is rated on a 
five-point Likert-scale from 0 (no disability) to 4 (total disability). Anchor definitions for 
each item are provided in the manual. The Mini-ICF was found to demonstrate good 
psychometric properties in its initial studies (Balestrieri et al., 2013; Baron and Linden, 2009; 
Linden and Baron, 2005; Molodynski et al., 2012).  
 
2.5. Statistical analyses 
Sample characteristics and their distributions across diagnostic subgroups are provided in 
Table 1. Descriptive statistics are provided in Table 2 for all study measures (Means, standard 
deviations, Cronbach’s Alpha) for both the total sample and separately by diagnostic 
subgroup. Group comparisons were conducted using Chi-square tests for categorical variables 
or by a one-way ANOVA omnibus F-test for continuous measures. In Table 2, multiple 
comparisons were made using Bonferroni post-hoc tests to determine which means differ 
between groups. 
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Bivariate associations between the HoNOS scales and other study measures were established 
using Product-Moment correlations (Table 3). In order to test whether the strength of the 
association of each of the HoNOS scales (total and subscales) and other measures depends on 
the diagnostic category (i.e. primary diagnosis at admission) a series of two-way analyses of 
variance (ANOVA) models were conducted (Table 4). We used a two-step approach, i.e. as a 
first step the categorical group variable and the predictor variable (GAF, CGI, Mini-ICF, or 
BSI) were entered into the model, followed by adding a group-by-predictor interaction term to 
the model in a second step. This allows to examine the main effects of each predictor and the 
group factor (diagnostic group) on the HoNOS as well as whether there is an interaction 
between the predictor and the group. In order to avoid possible problems with 
multicolinearity the continuous predictor variables were centered prior to modeling (Aiken et 
al., 1991; Judd and McClelland, 1989) When the omnibus F test for an interaction term was 
significant, a post hoc regression model was conducted to explore the simple slopes and their 
significance for each group level (Table 5). Then, we tested reference contrasts to determine 
whether these slopes differ among groups by indicating each group level as the reference one 
by one in order to compare it against the other levels. All ANOVA models were adjusted for 
socio-demographic variables and the number of previous hospitalizations. 
All analyses were conducted using Stata/SE 12 (StataCorp, 2011). 
 
3. Results 
Table 1 shows socio-demographic characteristics for the total sample as well as separately by 
diagnostic subgroup. One-thousand and seventy-nine subjects (62.8%) had a primary 
diagnosis of SUD, 274 (15.9%) a diagnosis of schizophrenia or psychotic disorder, 160 
11	
	
(9.3%) an affective disorder, 66 (3.8%) an anxiety or somatoform disorder, and 140 (8.1%) a 
PD. Groups differed significantly regarding sex, age, marital status, education, and the mean 
frequency of past hospital stays in our institution. For further details please refer to Table 1. 
 
‐ Insert Table 1 about here - 
 
Table 2 displays means and standard deviations (M and SD) as well as information on 
reliability (Cronbach´s Alpha) for all study measures for both the total sample as well as 
stratified by diagnostic subgroup. All study measures differed significantly across groups. 
SUD were linked to lower HoNOS total, symptom and social scores, higher HoNOS 
behavioral scores, lower BSI, CGI and Mini-ICF scores, as well as higher GAF scores. 
Psychotic disorders were associated with higher HoNOS total, impairment, symptom and 
social scores, with lower BSI and GAF scores as well as with higher CGI and Mini-ICF 
scores. Affective disorders were primarily associated with lower HoNOS behavioral and 
symptom scores. Anxiety or somatoform disorders and PD were associated with higher self-
reported psychopathology (BSI) while being more or less at the population mean level 
regarding all other study measures. The HoNOS total and subscales, except for the behavioral 
subscale, showed satisfactory internal consistencies (see Table 2). 
 
‐ Insert Table 2 about here - 
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Female sex was associated with higher impairment and symptom subscale scores as well as 
with higher BSI, CGI and Mini-ICF scores, but with lower HoNOS behavioral subscale and 
GAF scores (results not tabulated). The HoNOS total score, the behavioral, social and 
symptom subscale scores as well as the BSI and Mini-ICF scores were negatively associated 
with age, while the HoNOS impairment subscale score was positively associated with age 
(not tabulated). All study measures were significantly associated with education, all HoNOS 
scales (total and subscales) and the Mini-ICF were linked to marital status, and all measures, 
except for the HoNOS symptom scale and the BSI, which were linked to a higher number of 
previous hospital stays (not tabulated).  
Self-reported psychopathology (BSI) was available from only 51.7% of the study sample. To 
estimate the impact of missing data, cases with and without self-reported data were compared 
regarding sociodemographic and clinical variables. Accordingly, numbers of complete self-
report data varied significantly across diagnoses (Chi-Square=20.12; df=4; p<0.001): the 
respective figures of available data for SUD, psychotic disorders, affective disorders, anxiety 
or somatoform disorders, and PD were 50.7%, 43.4%, 59.4%, 59.1%, and 62.9%. Complete 
self-report data was further related to younger age (F1;1,717=19.63; p<0.001), higher education 
(Chi-Square=31.75; df=3; p<0.001; 55.7%, 56.7%, 44.4%, and 33.6% for university degree, 
apprenticeship/technical college, compulsory school, and not having completed compulsory 
school), and to single marital status (Chi-Square=17.42; df=3; p=0.001; 56.2%, 46.5%, 
47.4%, and 37.5% for single, married, separated/divorced, and widowed). Those with full 
data had significantly lower HoNOS total (F1;1,646=14.78; p<0.001), impairment 
(F1;1,636=47.92; p<0.001) and social scores (F1;1,491=5.52; p=0.019) as well as lower CGI 
(F1;1,716=27.70; p<0.001) and Mini-ICF scores (F1;1,691=13.47; p<0.001). Diagnosis-stratified 
analyses revealed these differences to be largest for either psychotic (HoNOS-total: 
F1;242=8.54; p=0.004; HoNOS-social: F1;180=9.18; p=0.003; Mini-ICF: F1;269=13.40; p<0.001) 
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or affective disorders (HoNOS-impairment: F1;150=16.95; p<0.001; CGI: F1;158=7.37; 
p=0.007). 
Table 3 displays the associations among all study measures. The HoNOS total score is highly 
correlated with all the subscales while the associations among the latter were rather low. 
Other observer-rated measures (GAF, CGI and Mini-ICF) were correlated with the HoNOS 
scales at low to medium level. The BSI was very weakly correlated to all other study 
measures and completely unrelated to the behavioral and impairment subscales of the 
HoNOS. 
 
‐ Insert Table 3 about here – 
	
Multivariate ANOVA models confirmed the association of all HoNOS scales with other 
measures (except for the HoNOS social – BSI link) as well as with the primary diagnosis at 
admission (see Table 4). The addition of an interaction term in a second step indicated that 
group membership significantly moderated the association between GAF and HoNOS-total 
(Model 1a), and HoNOS-symptom scales (Model 4a), between the Mini-ICF and all the 
HoNOS scales (Models 1c, 3c, 4c and 5c) except for the HoNOS-behavioral subscale, and 
between CGI and the HoNOS-behavioral (Model 2b) and HoNOS-symptom scales (Model 
4b).  
 
‐ Insert Table 4 about here – 
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A significant interaction term means that the regression lines for these associations differ 
significantly across groups. Table 5 displays the simple effects, i.e. the strength of the 
associations (slopes) between the HoNOS scale and another measure at the group level, as 
well as the simple contrasts, i.e. the test of differences between groups in the slopes of the 
significant overall interactions. Accordingly, the HoNOS total and symptom subscale scores 
were negatively linked to the GAF but not for anxiety or somatoform disorders. However, the 
associations differed not significantly between these groups except in those with SUD the 
symptom subscale was significantly lower linked to the GAF than in other groups. The Mini-
ICF was positively associated with the HoNOS total score and the social subscale for all 
groups and with the impairment and symptom subscales in all groups excepting for anxiety or 
somatoform disorders. These associations were significantly stronger in individuals with 
psychotic disorders compared to all other groups for the total scale as well as for the 
impairment scale and stronger than SUD for the social subscale. The CGI was positively 
related to the behavioral subscale in those with SUD, affective disorders and PD and to the 
symptom subscale in all groups except for the anxiety or somatoform diagnosis group. For the 
behavioral subscale these associations were higher for those with SUD and PD compared to 
the other groups and higher in the symptom subscale for those with psychotic and affective 
disorders. 
 
‐ Insert Table 5 about here – 
 
4. Discussion 
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This is the first study to examine the validity of the German version of the HoNOS in a very 
large clinical sample by directly contrasting different diagnostic subgroups. Indeed, we 
compared the associations of the HoNOS with other observer-rated scales of functioning and 
self-reports of mental health across the major categories of psychiatric disorders.  
Our sample primarily comprised patients with severe clinical profiles. Indeed, most patients 
were referred to our institution after failure of treatment in community or outpatient settings, 
mostly with a sub-acute symptom load and functional impairment. Therefore, it was not 
surprising that we found more severe scores on our study measures, including the HoNOS, 
than those reported in other studies (Andreas et al., 2007; Andreas et al., 2010a; Bech et al., 
2006; Berk et al., 2008; Goldney et al., 1998; Hatfield et al., 2000; Kisely et al., 2010; Trauer 
et al., 1999). In particular, the German validation studies of the HoNOS primarily focused on 
psychosomatic rehabilitation patients, while under-representing schizophrenia and bipolar 
patients (Andreas et al., 2007; Andreas et al., 2010a), who usually have a more severe course 
of disease and a higher degree of functional impairment. 
4.1. Associations with other measures 
In line with previous findings, associations of the HoNOS with other observer-rated 
instruments of functioning were superior to those with self-reports of mental health (Adams et 
al., 2000; Pirkis et al., 2005). In fact, the HoNOS has been described as a measure of 
functioning rather than as a tool for the assessment of symptoms (Bebbington et al., 1999; 
Egger et al., 2015; Lovaglio and Monzani, 2011). Additionally, since our service targets 
primarily on a specific population with rather sub-acute psychopathological symptoms as well 
as functional disturbances, low associations between the HoNOS scales (apart from the 
conceptually closely related symptoms subscale) and psychopathology were expected 
(Brooks, 2000; Oiesvold et al., 2011; Parabiaghi et al., 2005). Specific behavioral aspects 
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were not targeted in the current study; and therefore we observed overall low associations 
with the HoNOS behavioral problems subscale.  
4.2. Group comparisons 
Those patients with a psychotic disorder showed the poorest outcomes on almost all 
measures. Basically, schizophrenia and other psychotic disorders have a high clinical severity, 
along with overall impairment and disabilities (Whiteford et al., 2013). However, our data 
also suggest that patients with psychotic disorders were largely unaffected by behavioral 
impairment. A possible explanation might be that those patients were mostly referred to our 
clinic after initial treatment in an acute psychiatric facility. Symptoms leading to 
hospitalization (Dazzi et al., 2015; Jäger et al., 2014) are primarily encompassed by the 
HoNOS behavioral subscale (Wing et al., 1998). Those symptoms in particular tend to 
improve more quickly and therefore promote an earlier discharge, while cognitive symptoms 
and other impairment remain relatively stable over time (Jäger et al., 2014; Kelly et al., 1998; 
Müller et al., 2013). Interestingly, this group showed (together with SUD) the lowest scores 
on self-reported psychopathology, which was rather surprising, since almost all observer 
ratings indicated higher clinical severity. However, individuals with schizophrenia often have 
impaired illness insight, which might prevent them from reporting their symptoms accurately 
(McGorry and McConville, 2000). Alternatively, this could also be an artifact of the higher 
number of missing self-report data among patients with more severe clinical presentations. In 
fact, dropout analyses revealed that those with a primary diagnosis of psychotic disorders had 
partially poorer outcomes on other measures when self-reported data were not available. 
In contrast, those with a primary diagnosis of SUD had better outcomes on almost all 
measures, suggesting that this group has comparably higher overall functioning and lower 
psychopathology. However, higher behavioral dysfunction was observed among these 
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individuals, which, however, was not surprising since one out of the three items of the 
behavioral subscale of the HoNOS specifically focuses on substance consumption (Pirkis et 
al., 2005; Wing et al., 1994).  
Other diagnostic groups (i.e. affective, anxiety/somatoform and PD) were rated with all 
measures at intermediate levels between these two extreme groups, i.e. they scored higher 
than patients with SUD but lower than those with psychotic disorders. At a first glance it 
might be surprising that those heterogeneous diagnostic categories differ so little from each 
other in their observer ratings. However, the fact that there is only one item (item 8: “other 
mental and behavioral problems”) for a broad range of psychopathological symptoms (phobia, 
anxiety, obsessive-compulsive, mental tension, dissociative, somatoform, eating, sleep, 
sexual) (Wing et al., 1999) blurred the lines between certain psychiatric disorders, a point that 
has already been criticized in earlier studies on the HoNOS (Audin, 2001; Lovaglio and 
Monzani, 2011; Trauer et al., 1999; Wing et al., 1999). Other observer-rated measures (CGI, 
GAF and Mini-ICF), in contrast, focus primarily on functioning independently of symptoms 
(Guy, 1976; Jean Endicott et al., 1976; Linden and Baron, 2005); therefore the results indicate 
that even divergent psychopathological symptoms and diagnoses might be linked to similar 
levels of impairment. This becomes particularly evident as affective disorders, anxiety or 
somtoform disorders, and PD differ considerably in their self-reported psychopathology from 
SUD and psychotic disorders.  
Overall, although the HoNOS scales were associated with other observer-rated scales of 
functioning these associations varied considerably between diagnostic groups. Interaction 
analyses revealed that the variability in the HoNOS scales are not often explained by 
independent effects of either the diagnostic category or the measure of functioning (CGI, 
GAF, Mini-ICF), but rather by an interaction of both. No matter if total or subscales of the 
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HoNOS are considered, their relationships to other measures of functioning were more or less 
equal: while these associations in anxiety or somatoform disorders were either null or only 
small, significant associations were observed among other diagnostic groups. In detail, those 
with psychotic disorders mostly showed the strongest links, at least stronger than in those 
with SUD, which, in turn, showed rather weak associations. Those with affective disorders 
and PD more or less did not differ in their associations from each other, which might be due 
to the inability of the HoNOS to assess specific impairment for those disorders. On the other 
hand, as an exception, those with PD and SUD stood out in their associations with the 
HoNOS behavioral subscale. The items that were assessed by this subscale represent the 
principal symptoms that lead to admission and or treatment for either SUD or PD. 
4.3. Strengths of the study  
A major strength of our study was without doubt the use of a large representative clinical 
sample with a full examination of all admissions to one single psychiatric hospital during a 
three-year period. A further advantage was the standardized implementation of 
comprehensive and unselected assessments for all patients, which allowed for comparisons 
between diagnostic groups. To our knowledge, few studies have used the HoNOS as a 
permanent clinical tool, instead, most studies used it in “research settings” with no subsequent 
clinical integration (Kisely et al., 2010; Stein, 1999). A further important strength of the study 
is the simultaneous use of both self-report as well as observer-rated measures. 
4.4. Limitations 
Despite the strengths mentioned above, the current study also has some limitations, which 
must be acknowledged. First, the collection of measures we used to validate the HoNOS was 
more general rather than diagnosis-specific, which, however, allowed to compare associations 
19	
	
with the HoNOS across different diagnostic categories. Therefore, future investigations of the 
HoNOS’s performance in a more disease specific context should include more specific 
measures. Second, there was a high rate of missing data on self-reported psychopathology, 
particularly for those with schizophrenia, suggesting that bias cannot be excluded. Third, the 
majority of our sample was composed of patients with a chronic course of illness with 
probably a higher number of previous hospitalizations. However, since the health care system 
is open and allows personal choice of treatment, we unfortunately are not aware of the actual 
number and duration of previous hospitalizations. Therefore, in the current study, frequency 
of stays was restricted to admissions to our hospital only. Indeed, some patients may have had 
longer or more intensive treatment periods than others. Fourth, a major part of our study 
sample was comprised of patients with SUD while other diagnostic groups were rather small. 
However, this was based on a time-limited therapeutic intervention specifically for SUD, 
which leads to a higher patient turnover than in other diagnostic groups. Finally, a bias might 
arise from the patterns and amount of comorbid psychiatric disorders and/or other medical 
conditions, which were not taken into account in the current analysis. 
4.5. Final comments 
Contrary to initial expectations, the HoNOS and its subscales were not equally valid across 
different diagnostic groups (Wing et al., 1998). Within the constraints of our study, which 
have been mentioned, we can conclude that the HoNOS performed rather poorly in more 
severe and debilitating disorders. This weakness, however, has already been acknowledged in 
other studies (Andreas et al., 2011; Audin, 2001). Consequently, it might be problematic to 
apply the HoNOS as a stand-alone measure (Preston, 2000); (Goldney et al., 1998), especially 
if it has implications for quality control and financial decisions in mental health care (Speak et 
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al., 2015). Instead, it has been recommended to use the HoNOS as part of a comprehensive 
battery of instruments including diagnosis-specific measures (Hampson et al., 2011).  
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Table 1. 
Socio-demographic characteristics of the study sample and by diagnostic group 
  Total 
sample 
N=1,719 
(100.0%)  
Substanc
e use 
disorders 
N=1,079 
(62.8%) 
Psychoti
c 
disorders 
N=274 
(15.9%) 
Affective 
disorders 
N=160 
(9.3%) 
Anxiety 
and 
somatofo
rm 
disorders 
N=66 
(3.8%) 
Personalit
y 
disorders 
N=140 
(8.1%) 
Test (Chi-
square or 
one-way 
ANOVA) 
  N(%) N(%) N(%) N(%) N(%) N(%) p-value 
Female sex 606 (35.3) 306 
(28.4) 
110 
(40.2) 
81 (50.6) 31 
(47.00) 
78 (55.7) <0.001 
Age in years (MSD) 43.811.8 46.611.
0 
38.812.
0 
44.110.
7 
38.49.8 34.810.6 <0.001 
Marital status Single 900 (52.4) 524 
(48.6) 
199 
(72.6) 
55 (34.4) 31 (47.0) 91 (65.0) <0.001 
Married 312(18.2) 199 
(18.5) 
28 (10.2) 51 (31.9) 15 (22.7) 19 (13.6) 
Separated/di
vorced 
466 (27.1) 324 
(30.1) 
45 (16.4) 52 (32.5) 15 (22.7) 30 (21.4) 
Widowed 40 (2.3) 31 (2.9) 2 (0.7) 2 (1.3) 5 (7.6) 0 (0.0) 
Education not 
completed 
compulsory 
school 
119 (6.9) 59 (5.5) 40 (14.6) 4 (2.5) 7 (10.6) 9 (6.4) <0.001 
Compulsory 
school 
270 (15.7) 125 
(11.6) 
59 (21.5) 35 (21.9) 13 (19.7) 38 (27.1) 
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Apprentices
hip/technica
l college 
933 (54.3) 640 
(59.3) 
97 (35.4) 82 (51.3) 36 (54.6) 78 (55.7) 
Secondary 
school/ 
college/univ
ersity 
271 (15.8) 192 
(17.8) 
35 (12.8) 28 (17.5) 7 (10.6) 9 (6.4) 
N/A 126 (7.3) 63 (5.8) 43 (15.7) 11 (6.9) 3 (4.6) 6 (4.3) 
Previous 
hospitalization 
to our 
institution 
Frequency 
of hospital 
stays 
(MSD) 
2.24.1 2.32.4 2.97.1 1.01.8 1.11.7 1.93.7 <0.001 
Note: M=mean; SD=standard deviation 
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Table 2. 
Reliability and descriptive statistics of study measures for the total sample and stratified by diagnostic groups 
 Cronbac
hs Alpha 
Total Substance 
use disorders 
(ICD-10 F1) 
Psychotic 
disorders 
(ICD-10 
F2) 
Affective 
disorders 
(ICD-10 F3) 
Anxiety and 
somatoform 
disorders 
(ICD-10 F4) 
Personality 
disorders 
(ICD-10 F6) 
P-value Group comparisons 
 M±SD M±SD M±SD M±SD M±SD M±SD   
HoNOS-total 0.76 15.9 ±7.0 14.4±6.6 20.8±7.8 17.4±6.0 16.1±4.6 16.8 ±6.1 <0.001 F1<F2,F3,F6 
F2>F3,F4,F6 
HoNOS-
behavioral 
0.16 2.8±2.0 3.1±1.9 2.3±2.2 1.8±1.7 2.0±1.7 2.9±2.1 <0.001 F1>F2,F3,F4 
F3,F4<F6 
HoNOS-
impairment 
0.53 2.6±1.8 2.5±1.8 3.3±2.0 2.6±1.7 1.9±1.8 1.8±1.5 <0.001 F1,F2,F3>F6 
F2>F1,F3,F4 
HoNOS-
symptom 
0.50 4.7±2.4 3.6±1.9 7.2±2.5 6.4±2.1 5.7±1.5 5.3±1.9 <0.001 F1<F2,F3,F4,F6 
F2>F3,F4,F6 
F3>F6 
HoNOS-social 0.76 6.1±3.7 5.2±3.5 9.0±3.9 7.1±3.0 6.5±2.8 7.3±2.9 <0.001 F1<F2,F3,F4,F6 
F2>F3,F4,F6 
BSI-GSI 0.97 52.4±37.5 43.5±32.0 50.6±36.5 71.5±45.5 72.3±40.7 81.1±35.4 <0.001 F1,F2<F3,F4,F6 
GAF - 39.2±11.2 41.1±11.4 33.8±9.7 36.7±9.9 39.8±11.3 37.9±8.6 <0.001 F1>F2,F3,F6 
F2<F4,F6 
CGI - 5.2±0.9 5.1±0.9 5.8±0.9 5.3±0.8 5.3±0.9 5.4±0.8 <0.001 F1<F2,F3,F6 
F2>F3,F4,F6 
Mini-ICF 0.94 18.9±10.7 16.1±10.6 25.7±9.6 22.1±9.2 20.9±8.4 23.0±7.9 <0.001 F1<F2,F3,F4,F6 
F2>F3,F4 
Note: ICD-10=International Classification of Diseases, 10th Edition; HoNOS= Health of the Nations Outcome Scales; BSI-GSI=Brief Symptom 
Inventory-Global Severity Index; GAF=Global Assessment of Functioning; CGI=Clinical Global Impression; Mini-ICF=Mini International 
Classification of Functioning; M=mean; SD=standard deviation 
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Table 3. 
Bivariate associations among HoNOS (total and subscales) and measures of psychopathology or functioning 
 1. 2. 3. 4. 5. 6. 7. 8. 9
.
1. HoNOS-
total 
-         
2. HoNOS-
behavioral 
0.54*** -        
3. HoNOS-
impairment 
0.62*** 0.22*** -       
4. HoNOS-
symptom 
0.72*** 0.13*** 0.33*** -      
5. HoNOS-
social 
0.87*** 0.30*** 0.40*** 0.55*** -     
6. BSI-GSI 0.18*** 0.04 0.04 0.28*** 0.13*** -    
7. GAF -0.38*** -0.19*** -0.27*** -0.33*** -0.31*** -0.20*** -   
8. CGI 0.50*** 0.24*** 0.40*** 0.44*** 0.38*** 0.13*** -0.44*** -  
9. Mini-ICF-
APP 
0.54*** 0.20*** 0.34*** 0.44*** 0.51*** 0.13*** -0.21*** 0.36*** -
Note: *** p<0.001; HoNOS= Health of the Nations Outcome Scales; BSI-GSI=Brief Symptom Inventory-Global Severity Index; GAF=Global 
Assessment of Functioning; CGI=Clinical Global Impression; Mini-ICF=Mini International Classification of Functioning.
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Table 4. 
Two-way ANOVA models with interactions for the effect of functioning or mental health and 
diagnostic group on the HoNOS  
Outcome  Step
s 
 F df p-value R-
square 
HoNOS-
total 
Model 1a 1 Diagnostic group 20.97 4;1521 <0.001 0.231 
GAF 168.52 1;1521 <0.001 
2 Diagnostic 
group*GAF 
2.74 4;1517 0.027 0.236 
Model 
1b 
1 Diagnostic group 16.13 4;1521 <0.001 0.308 
CGI 358.34 1;1521 <0.001 
2 Diagnostic group*CGI 1.33 4;1517 0.256 0.311 
Model 1c 1 Diagnostic group 11.38 4;1507 <0.001 0.338 
Mini-ICF 433.38 1;1507 <0.001 
2 Diagnostic 
group*Mini-ICF 
8.00 4;1503 <0.001 0.352 
Model 
1d 
1 Diagnostic group 11.75 4;804 <0.001 0.152 
BSI 17.73 1;804 <0.001 
2 Diagnostic group*BSI 1.84 4;800 0.120 0.160 
HoNOS-
behavior
al 
Model 2a 1 Diagnostic group 34.18 4;1540 <0.001 0.157 
GAF 85.12 1;1540 <0.001 
2 Diagnostic 
group*GAF 
0.76 4;1536 0.550 0.159 
Model 
2b 
1 Diagnostic group 42.28 4;1540 <0.001 0.200 
CGI 164.89 1;1540 <0.001 
2 Diagnostic group*CGI 7.78 4;1536 <0.001 0.213 
Model 2c 1 Diagnostic group 41.66 4;1524 <0.001 0.180 
Mini-ICF 132.39 1;1524 <0.001 
2 Diagnostic 
group*Mini-ICF 
0.47 4;1520 0.760 0.181 
Model 
2d 
1 Diagnostic group 15.01 4;815 <0.001 0.129 
BSI 5.53 1;815 0.019 
2 Diagnostic group*BSI 0.77 4;811 0.546 0.132 
HoNOS-
impairm
ent 
Model 3a 1 Diagnostic group 10.85 4;1509 <0.001 0.183 
GAF 84.04 1;1509 <0.001 
2 Diagnostic 
group*GAF 
0.54 4;1505 0.706 0.184 
Model 
3b 
1 Diagnostic group 9.51 4;1509 <0.001 0.240 
CGI 204.30 1;1509 <0.001 
2 Diagnostic group*CGI 2.20 4;1505 0.067 0.245 
Model 3c 1 Diagnostic group 11.11 4;1495 <0.001 0.237 
Mini-ICF 194.02 1;1495 <0.001 
2 Diagnostic 
group*Mini-ICF 
4.32 4;1491 0.002 0.246 
Model 
3d 
1 Diagnostic group 10.16 4;797 <0.001 0.165 
BSI 10.68 1;797 0.001 
2 Diagnostic group*BSI 0.58 4;793 0.679 0.168 
34	
	
HoNOS-
sympto
m 
Model 4a 1 Diagnostic group 130.49 4;1545 <0.001 0.374 
GAF 94.90 1;1545 <0.001 
2 Diagnostic 
group*GAF 
8.38 4;1541 <0.001 0.388 
Model 
4b 
1 Diagnostic group 121.54 4;1545 <0.001 0.420 
CGI 225.44 1;1545 <0.001 
2 Diagnostic group*CGI 9.45 4;1541 <0.001 0.434 
Model 4c 1 Diagnostic group 109.06 4;1529 <0.001 0.398 
Mini-ICF 157.44 1;1529 <0.001 
2 Diagnostic 
group*Mini-ICF 
12.15 4;1525 <0.001 0.416 
Model 
4d 
1 Diagnostic group 68.61 4;818 <0.001 0.337 
BSI 36.12 1;818 <0.001 
2 Diagnostic group*BSI 0.60 4;814 0.662 0.339 
HoNOS-
social 
Model 5a 1 Diagnostic group 26.82 4;1381 <0.001 0.218 
GAF 85.65 1;1381 <0.001 
2 Diagnostic 
group*GAF 
1.08 4;1377 0.363 0.220 
Model 
5b 
1 Diagnostic group 24.93 4;1381 <0.001 0.249 
CGI 146.07 1;1381 <0.001 
2 Diagnostic group*CGI 0.76 4;1377 0.550 0.250 
Model 5c 1 Diagnostic group 14.36 4;1369 <0.001 0.327 
Mini-ICF 318.30 1;1369 <0.001 
2 Diagnostic 
group*Mini-ICF 
3.28 4;1365 0.011 0.334 
Model 
5d 
1 Diagnostic group 11.78 4;737 <0.001 0.150 
BSI 2.07 1;737 0.151 
2 Diagnostic group*BSI 2.33 4;733 0.055 0.161 
Note: All models were adjusted for sex, age, education, marital status and frequency of 
previous hospitalizations; Health of the Nations Outcome Scales; BSI-GSI=Brief Symptom 
Inventory-Global Severity Index; GAF=Global Assessment of Functioning; CGI=Clinical 
Global Impression; Mini-ICF=Mini International Classification of Functioning; df=degrees of 
freedom; df may vary as a function of missing data 
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Table 5. 
Simple effects (unstandardized coefficients) and simple contrasts of significant interactions 
Outcome   Unstandardized 
coefficients ± 
SE a 
p-value Significant 
contrasts 
HoNOS-
total 
Model 1a F1 x GAF -1.98±0.20 <0.001 F2 vs F4* 
F3 vs F4* 
F4 vs F6* 
F2 x GAF -2.75±0.48 <0.001 
F3 x GAF -3.14±0.58 <0.001 
F4 x GAF -0.70±0.78 0.368 
F6 x GAF -3.27±0.73 <0.001 
Model 1c F1 x Mini-
ICF 
2.87±0.19 <0.001 F1 vs F2*** 
F2 vs F3* 
F2 vs F4* 
F2 vs F6* 
F2 x Mini-
ICF 
5.44±0.43 <0.001 
F3 x Mini-
ICF 
3.99±0.59 <0.001 
F4 x Mini-
ICF 
2.78±0.97 0.004 
F6 x Mini-
ICF 
3.37±0.69 <0.001 
HoNOS-
behavior
al 
Model 
2b 
F1 x CGI 0.74±0.06 <0.001 F1 vs F2*** 
F1 vs F3* 
F2 vs F6*** 
F3 vs F6** 
F4 vs F6* 
F2 x CGI 0.09±0.13 0.489 
F3 x CGI 0.37±0.17 0.025 
F4 x CGI 0.34±0.27 0.207 
F6 x CGI 1.07±0.18 <0.001 
HoNOS-
impairm
ent 
Model 2c F1 x Mini-
ICF 
0.55±0.05 <0.001 F1 vs F2*** 
F2 vs F3** 
F2 vs F4* 
F2 vs F6* 
 
 
F2 x Mini-
ICF 
1.05±0.12 <0.001 
F3 x Mini-
ICF 
0.44±0.16 0.006 
F4 x Mini-
ICF 
0.47±0.27 0.077 
F6 x Mini-
ICF 
0.52±0.19 0.006 
HoNOS-
sympto
m 
Model 4a F1 x GAF -0.36±0.06 <0.001 F1 vs F2*** 
F1 vs F3** 
F1 vs F6** 
F2 vs F4*** 
F3 vs F4** 
F4 vs F6** 
F2 x GAF -1.05±0.15 <0.001 
F3 x GAF -0.90±0.18 <0.001 
F4 x GAF -0.03±0.24 0.915 
F6 x GAF -1.01±0.23 <0.001 
Model 
4b 
F1 x CGI 0.60±0.06 <0.001 F1 vs F2*** 
F1 vs F3** 
F2 vs F4*** 
F3 vs F4** 
 
F2 x CGI 1.38±0.13 <0.001 
F3 x CGI 1.18±0.17 <0.001 
F4 x CGI 0.33±0.28 0.240 
F6 x CGI 0.96±0.19 <0.001 
Model 4c F1 x Mini- 0.45±0.06 <0.001 F1 vs F2*** 
36	
	
ICF F1 vs F3*** 
F2 vs F4* 
F2 vs F6** 
 
F2 x Mini-
ICF 
1.40±0.14 <0.001 
F3 x Mini-
ICF 
1.18±0.19 <0.001 
F4 x Mini-
ICF 
0.61±0.31 0.050 
F6 x Mini-
ICF 
0.70±0.22 0.002 
HoNOS-
social 
Model 5c F1 x Mini-
ICF 
1.40±0.10 <0.001 F1 vs F2*** 
 
F2 x Mini-
ICF 
2.35±0.25 <0.001 
F3 x Mini-
ICF 
1.65±0.33 <0.001 
F4 x Mini-
ICF 
1.58±0.56 0.005 
F6 x Mini-
ICF 
1.80±0.39 <0.001 
Note:  All models were adjusted for sex, age, education, marital status and frequency of 
previous hospitalizations;  *** p<0.001; ** p<0.01; * p<0.05; SE=Standard error; 
HoNOS=Health of the Nations Outcome Scales; GAF=Global Assessment of Functioning; 
CGI=Clinical Global Impression; Mini-ICF=Mini International Classification of Functioning; 
F1=Substance use disorders; F2=Schizophrenia and psychotic disorders; F3=Affective 
disorders; F4=Anxiety/somatoform disorders; F6=Personality disorders  
	
 
